André Kahan

[vc_row][vc_column][vc_column_text] Cardiovascular (CV) disease is now recognized as a major cause of morbidity and mortality in patients with rheumatoid arthritis (RA)1,2. Identifying patients with RA at a preclinical stage and/or at high risk of myocardial may allow for the development of preventive strategies. [/vc_column_text][vc_separator type="transparent" position="center" thickness="5" width_in_percentages=""...

[vc_row][vc_column][vc_column_text] Autoimmune diseases include more than 70 different disorders, affecting over 5% of the population of the Western countries. They are a well-known cause of morbidity and mortality. [/vc_column_text][vc_separator type="transparent" position="center" thickness="5" width_in_percentages="" up="10" down="10"][vc_column_text] [button size='medium' style='' text='Télécharger la publication' icon='fa-download' icon_color='' link='https://www.cochin-poa.com/wp-content/uploads/2015/09/publication-rhumatologie-A-2.pdf' target='_blank' color='' hover_color='' border_color='' hover_border_color=''...

[vc_row][vc_column][vc_column_text] Autoantibodies are useful for determinations of the diagnosis and prognosis of the various types of inflammatory chronic rheumatisms. Anticitrullinated protein antibodies (ACPA), like anticyclic citrullinated peptide antibodies (anti-CCP), have proven effective as diagnostic markers for rheumatoid arthritis (RA). [/vc_column_text][vc_separator type="transparent" position="center" thickness="5" width_in_percentages="" up="10" down="10"][vc_column_text] [button size='medium' style=''...